The deal, which largely involves Surmodics' SurVeil drug-coated balloon, would give Abbott worldwide commercialization rights once the device receives FDA approval.
Health Care + Med Tech
Fast Company highlighted the Minneapolis medical startup on its Top 50 list.
Shrinking talent pools of registered nurses and primary-care doctors are a growing issue for hospitals, survey says.
The Minneapolis startup provides free and convenient transportation for low-income, uninsured and vulnerable patients.
The company is currently developing a drug for market approval that treats lower back pain.
The health care organization plans to have a successor picked by early fall.
Stem cells from new automated platform in Florida could be used in Rochester.
A rebuttal to TCB's story titled "Insurance Industry Report Blames Prescribers for Opioid Crisis."
A review of claims data found inconsistent adherence to new CDC prescribing guidelines.
The development of 'cerebral organoids' from stem cells could impact the fight against Parkinson's disease.
The nonprofit insurer's board has tapped current board member Kathleen Blatz as its interim leader.
Though most are okay with how much they're paying for their employer-based coverage.
Indiana-based Recovery Force makes microprocessor-controlled compression wraps.
The state's Department of Employment and Economic Development has offered the company a grant that, if it meets its investment and hiring goals, will cover nearly half of the expansion's costs.
The former key player behind the Affordable Care Act has launched a collaborative nonprofit to continue the mission of providing health care to all American citizens.
The urology and gynecology device maker also reported preliminary fourth quarter results that suggest double-digit sales growth year-over-year.
However, the survey found that most workers were satisfied with their own health benefits.
This is the second recent biotech investment from the young nonprofit.